Target intelligence / Profile preview

H2B.L histone variant 1, pseudogene (H2BL1P)

Target
H2BL1P
Molecular classification
Pseudogene, Histone (H2B variant family, non-functional), Other
01

Overview

H2B.L histone variant 1, pseudogene (H2BL1P) is a member of the histone H2B family pseudogenes in humans and mice[2][4][7]. Unlike functional H2B genes, which encode the core histone proteins critical for chromatin structure and genome packaging, H2BL1P contains disrupted coding and regulatory regions that preclude expression of a functional histone protein[6]. The existence of H2B pseudogenes like H2BL1P reflects the evolutionary turnover and gene duplication events that expand and diversify histone gene families[1]. Pseudogenes do not have a known physiological or pathological role, do not produce protein, and are not present as therapeutic targets, biomarkers, or relevant disease genes[2][4][6][7]. Variant forms of functional H2B genes do exist (such as H2B.L/subH2B in mice and humans), and functional H2B variants can participate in chromatin remodeling in gametogenesis and development[1], but H2BL1P itself is a nonfunctional allele.

Other names
1700024P04RikSubH2BvH2BP4H2B histone pseudogene 4
02

Mechanism of action

Not applicable

03

Biological functions

None; as a pseudogene it does not encode a functional protein product and has no direct biological function
04

Disease associations

None directly established; histone pseudogenes are generally not implicated in disease as functional molecular agents. Histone H2B pseudogenes as a group reflect evolutionary turnover but individual pseudogenes like H2BL1P are not associated with specific disease phenotypes
05

Safety considerations

None noted; as it does not encode a functional protein, there are no relevant safety or therapeutic concerns.
06

Interacting drugs

None. There are no approved or experimental drugs known to interact with this pseudogene.
07

Biomarkers

None directly established.

Beyond the preview

Go deeper on H2B.L histone variant 1, pseudogene (H2BL1P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on H2B.L histone variant 1, pseudogene (H2BL1P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call